NOV 15, 2018 2:17 PM PST

Anti-inflammatory Drug Works Like an Inhibitor

WRITTEN BY: Nouran Amin

At Karolinska Institutet in Sweden, a team of scientists from multiple disciplines have worked together to develop an inflammation inhibitor.

Credit: The Scientist

The new anti-inflammatory drug molecule possess a unique mechanism of action. Essentially, the drug works by inhibiting a certain protein, called OGG1, which is studied to repair DNA was found to cause a reduction in the signals that trigger an inflammation.

The inhibitor works by blocking the release of inflammatory proteins, such as TNF alpha. During investigations on mice with acute pulmonary disease, the drug was found to dampen the inflammation.

Learn more about inflammatory responses:

In collaboration with the University of Texas Medical Branch, Uppsala University and Stockholm University--results of the findings are described in a publication in Science.

"We've developed a new drug molecule that inhibits inflammation," explains co-leader of the study, Professor Thomas Helleday, at the Department of Oncology-Pathology, Karolinska Institutet, Sweden. "It acts on a protein that we believe is a general mechanism for how inflammation arises in cells."

Discovery of the anti-inflammatory drug was the product of a long-term investigation on the mechanisms behind DNA repair—with the objective of fighting cancer by targeting a tumors cell’s DNA. Such research has resulted in several breakthrough drug discoveries including PARP inhibitors for the treatment of congenital breast and ovarian cancer.

Researchers were originally investigating the development of a new molecule that inhibits the enzyme, OGG1, which was found to be responsible for oxygen damage to DNA—that’s when they discovered that the molecule also dampened inflammation.

The result concluded that OGG1, apart from repairing DNA, triggers inflammation—making its inhibition critical in the treatment for inflammatory diseases.

"This discovery could give rise to a new treatment for a very serious condition," says Professor Helleday. "We'll now be developing our OGG1 inhibitor and examining whether it can lead to new treatments for inflammatory diseases in order to cure or relieve diseases such as sepsis, COPD and severe asthma."

Source: Science Magazine

About the Author
BS/MS
Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
MAY 25, 2022
Neuroscience
The Connection Between Bizarre Dreams and Deeper Learning
MAY 25, 2022
The Connection Between Bizarre Dreams and Deeper Learning
A study published in eLife found that wakefulness, non-REM, and REM sleep have complementary functions for learning. Uni ...
JUN 02, 2022
Drug Discovery & Development
NSAIDs Can Have Different, Unexpected Effects on People. Why?
JUN 02, 2022
NSAIDs Can Have Different, Unexpected Effects on People. Why?
Non-steroidal anti-inflammatory drugs (NSAIDs) are among the most common types of drugs used to treat pain and inflammat ...
JUN 04, 2022
Drug Discovery & Development
Antibiotics Reduce Motivation to Exercise in Mice
JUN 04, 2022
Antibiotics Reduce Motivation to Exercise in Mice
Antibiotics may decrease athletes' motivation and endurance via effects on the microbiome. The corresponding study w ...
JUN 10, 2022
Cannabis Sciences
Are Cannabis Users Nicer?
JUN 10, 2022
Are Cannabis Users Nicer?
A study published in Nature offers evidence that cannabis has a positive effect on the psychosocial health of young adul ...
JUN 15, 2022
Plants & Animals
Using Mosquito Spit to Develop Vaccines for Zika, Yellow Fever, Dengue
JUN 15, 2022
Using Mosquito Spit to Develop Vaccines for Zika, Yellow Fever, Dengue
Mosquitoes, specifically, the Aedes mosquito, can carry and transmit deadly virsues like the Zika virus and the viruses ...
JUN 27, 2022
Drug Discovery & Development
Potential Gene Targets Identified for Treating Deafness
JUN 27, 2022
Potential Gene Targets Identified for Treating Deafness
Researchers have identified three mutations of the MINAR2 gene that are linked to deafness. They say that the mutations ...
Loading Comments...